MPS Loria Financial Planners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.48M | Buy |
15,980
+109
| +0.7% | +$24.2K | 0.92% | 9 |
|
|
2025
Q4 | $3.63M | Sell |
15,871
-35
| -0.2% | -$7.97K | 0.93% | 10 |
|
|
2025
Q3 | $3.68M | Sell |
15,906
-119
| -0.7% | -$24.2K | 0.98% | 10 |
|
|
2025
Q2 | $2.97M | Sell |
16,025
-414
| -3% | -$76.9K | 0.88% | 11 |
|
|
2025
Q1 | $3.44M | Buy |
16,439
+114
| +0.7% | +$22.2K | 1.02% | 11 |
|
|
2024
Q4 | $2.9M | Buy |
16,325
+125
| +0.8% | +$23K | 0.86% | 11 |
|
|
2024
Q3 | $3.2M | Sell |
16,200
-1,094
| -6% | -$204K | 0.95% | 11 |
|
|
2024
Q2 | $2.97M | Buy |
17,294
+119
| +0.7% | +$19.7K | 0.96% | 11 |
|
|
2024
Q1 | $3.13M | Sell |
17,175
-1,497
| -8% | -$258K | 1.05% | 10 |
|
|
2023
Q4 | $2.89M | Buy |
18,672
+132
| +0.7% | +$19.2K | 1.02% | 8 |
|
|
2023
Q3 | $2.76M | Buy |
18,540
+119
| +0.6% | +$17.5K | 1.08% | 8 |
|
|
2023
Q2 | $2.48M | Buy |
18,421
+122
| +0.7% | +$17.9K | 0.93% | 9 |
|
|
2023
Q1 | $2.92M | Buy |
18,299
+261
| +1% | +$39.9K | 1.18% | 8 |
|
|
2022
Q4 | $2.92M | Buy |
18,038
+122
| +0.7% | +$18.7K | 1.3% | 8 |
|
|
2022
Q3 | $2.4M | Sell |
17,916
-616
| -3% | -$88.4K | 0.93% | 11 |
|
|
2022
Q2 | $2.84M | Sell |
18,532
-2,183
| -11% | -$334K | 1.28% | 7 |
|
|
2022
Q1 | $3.36M | Buy |
20,715
+6
| +0% | +$872 | 1.41% | 6 |
|
|
2021
Q4 | $2.8M | Sell |
20,709
-2,285
| -10% | -$270K | 1.14% | 8 |
|
|
2021
Q3 | $2.48M | Buy |
22,994
+179
| +0.8% | +$20.5K | 1.14% | 9 |
|
|
2021
Q2 | $2.57M | Sell |
22,815
-3
| -0% | -$338 | 1.18% | 8 |
|
|
2021
Q1 | $2.47M | Buy |
22,818
+151
| +0.7% | +$16.2K | 1.15% | 9 |
|
|
2020
Q4 | $2.39M | Buy |
22,667
+522
| +2% | +$50.2K | 1.07% | 9 |
|
|
2020
Q3 | $1.94M | Sell |
22,145
-810
| -4% | -$76.3K | 1% | 11 |
|
|
2020
Q2 | $2.25M | Sell |
22,955
-426
| -2% | -$37.5K | 1.21% | 8 |
|
|
2020
Q1 | $1.78M | Buy |
23,381
+398
| +2% | +$33.9K | 1.37% | 8 |
|
|
2019
Q4 | $2.03M | Buy |
22,983
+25
| +0.1% | +$2.08K | 1.2% | 10 |
|
|
2019
Q3 | $1.74M | Buy |
22,958
+269
| +1% | +$18.4K | 1.13% | 11 |
|
|
2019
Q2 | $1.65M | Buy |
22,689
+59
| +0.3% | +$4.64K | 1.05% | 12 |
|
|
2019
Q1 | $1.82M | Buy |
22,630
+215
| +1% | +$17.6K | 1.21% | 9 |
|
|
2018
Q4 | $2.07M | Buy |
22,415
+44
| +0.2% | +$3.87K | 1.48% | 9 |
|
|
2018
Q3 | $2.12M | Buy |
22,371
+394
| +2% | +$37.4K | 1.32% | 9 |
|
|
2018
Q2 | $2.04M | Buy |
21,977
+322
| +1% | +$31.4K | 2.05% | 9 |
|
|
2018
Q1 | $2.05M | Sell |
21,655
-865
| -4% | -$95K | 1.44% | 9 |
|
|
2017
Q4 | $2.18M | Sell |
22,520
-114
| -0.5% | -$10.7K | 1.49% | 11 |
|
|
2017
Q3 | $2.01M | Buy |
22,634
+160
| +0.7% | +$12.2K | 1.44% | 12 |
|
|
2017
Q2 | $1.58M | Buy |
+22,474
| New | +$1.51M | 1.06% | 13 |
|
Other funds holding ABBV
VCM
VPM
MPS Loria Financial Planners's ABBV Position: Q1 2026 in Review
MPS Loria Financial Planners increased its AbbVie (ABBV) stake by 0.69% in Q1 2026, buying an estimated $24.2K and bringing the position to 15,980 shares worth $3.48M. The position accounts for 0.92% of the portfolio, ranked #9.
MPS Loria Financial Planners first reported a position in ABBV in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.68M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- MPS Loria Financial Planners held 15,980 shares of AbbVie worth $3.48M as of Q1 2026.
- MPS Loria Financial Planners bought 109 AbbVie shares in Q1 2026, an estimated $24.2K.
- AbbVie made up 0.92% of MPS Loria Financial Planners's portfolio in Q1 2026, its #9 holding.
- MPS Loria Financial Planners first reported a position in AbbVie in Q2 2017 and has held it in 36 quarters since.
- MPS Loria Financial Planners's AbbVie position peaked at $3.68M in Q3 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on MPS Loria Financial Planners's 13F filing for Q1 2026, filed 8 May 2026.